CVHIF CONVALO HEALTH INTERNATIONAL

BLVD Centers Posts First Fiscal Quarter Figures for Period Ending May 31, 2018

BLVD Centers Posts First Fiscal Quarter Figures for Period Ending May 31, 2018

LOS ANGELES, July 31, 2018 (GLOBE NEWSWIRE) --

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BLVD Centers Corporation (“BLVD” or the “Company”) (CSE:BLVD) today posted its financial statements for the quarter ended May 31, 2018.

Selected Highlights:

  • Revenue remained steady at just above $30,000,000 annualized.
  • Cash increased to $6,695,000 as cash flow improved.
  • Generated $745,000 in cash flow from operating activities.
  • Adjusted EBITDA (refer to MD&A) was slightly negative at $274,000 

“We have strong and stable operations which is bringing in cash each month,” said CEO Chris Heath. “We continue to have significant revenue and a strong and building balance sheet. Once again, the first quarter statements highlight the nature of our opportunity to be a platform company with which to launch into the marijuana industry. With solid eight figure revenues and a strong balance sheet, as well as several locations on the west coast and a deep database with thousands of patients in need of addiction services and products, we are very well placed to take advantage of the market.”

“We continue to work toward a transaction in the marijuana industry,” continued Mr. Heath. “We anticipate that company’s interested in a transaction with us will view our footprint and market presence as a tremendous platform with significant revenue opportunities as a result. Each has a differing view on how to monetize the marijuana opportunities in our centers. We are now focused on vetting these potential deals and interested parties. Ultimately we will work to choose the one that provides maximum shareholder value.”

Completion of any transaction would be subject to a number of conditions, including but not limited to, applicable regulatory, stock exchange, director and shareholder approvals. There can be no assurance that a transaction will be agreed to or completed.

The Company’s financial statements for the three months ended May 31, 2018 and 2017 and accompanying Management's Discussion & Analysis (MD&A) have been filed on SEDAR and are available at .

Non-GAAP Measures

This press release refers to "Adjusted EBITDA" which is a non-GAAP and non-IFRS financial measure that does not have a standardized meaning prescribed by GAAP or IFRS. The Company's presentation of this financial measure may not be comparable to similarly titled measures used by other companies. This financial measure is intended to provide additional information to investors concerning the Company's performance. Adjusted EBITDA is defined as EBITDA excluding stock based compensation and gains/losses on financial derivatives. Adjusted EBITDA is a Non-IFRS measure the Company uses as an indicator of financial health, and excludes several items which may be useful in the consideration of the financial condition of the Company, including interest expense, taxes, depreciation, amortization, stock based compensation, good will impairment and gain/losses on financial derivatives. The following table shows our Non-IFRS measure (Adjusted EBITDA) reconciled to our net income for the indicated periods:

('000 CAD)   Three Months Ended
Category   May 31, 2018
Net Income (loss)    $   (770)
Add Back: 
Depreciation and Amortization  192 
Interest Expense/(Interest Income)  115 
Amortization of non-cash prepaid real estate option fee 123 
Provision for income taxes    - 
EBITDA     $   (340)
Add Back: 
Stock-based compensation  61 
One-time non-recurring cost  - 
Facility set up     5 
Adjusted EBITDA    $   (274)
        

Management uses these non-GAAP measures as key metrics in the evaluation of the Company's performance and the consolidated financial results. The Company believes these non-GAAP measures are useful to investors in their assessment of the operating performance and the valuation of the Company. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and, in order to assure that all investors have access to similar data, the Company has determined that it is appropriate to make this data available to all investors. However, non-GAAP financial measures are not prepared in accordance with GAAP, and the information is not necessarily comparable to other companies and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Forward-Looking Statements

Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, including, the Company completing a transaction/merger with a company in the cannabis industry, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: changes in law; the ability to implement business strategies and pursue business opportunities; the state of the capital markets; the availability of funds and resources to pursue operations; decline of reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses in highly regulated businesses and industries; competition; changes in healthcare regulations or insurance coverage, particularly those relating to mental health or younger citizens; difficulty integrating newly acquired businesses; the time, outcome and cost of any inquiries, audits or litigation with insurance providers, or federal, state or local regulators; low profit market segments; fluctuations in exchange rates; investing in companies or projects which have limited or no operating history and/or are engaged in activities currently considered illegal under US Federal laws; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company's disclosure documents filed with the securities regulatory authorities in certain provinces of Canada and available at Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars unless otherwise indicated.

BLVD Centers Corporation

Nitin Kaushal

Director

(424) 372-1123



EN
31/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONVALO HEALTH INTERNATIONAL

 PRESS RELEASE

BLVD Centers Posts First Fiscal Quarter Figures for Period Ending May ...

BLVD Centers Posts First Fiscal Quarter Figures for Period Ending May 31, 2018 LOS ANGELES, July 31, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BLVD Centers Corporation (“BLVD” or the “Company”) (CSE:BLVD) today posted its financial statements for the quarter ended May 31, 2018. Selected Highlights: Revenue remained steady at just above $30,000,000 annualized.Cash increased to $6,695,000 as cash flow improved.Generated $745,000 in cash flow from operating activities.Adjusted EBITDA...

 PRESS RELEASE

BLVD Centers Begins Trading on Canadian Securities Exchange; Voluntari...

BLVD Centers Begins Trading on Canadian Securities Exchange; Voluntarily Delists From TSX Venture Exchange NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, June 26, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“BLVD” or the “Company”) (CSE:BLVD), in advance of its’ plan to execute becoming a marijuana focused company, is pleased to announce that the trading of its common shares on the Canadian Securities Exchange (the “CSE”) will commence at the market open today. With effect on the close of business on June 25, 2018, ...

 PRESS RELEASE

BLVD Centers Provides Update

BLVD Centers Provides Update NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, June 13, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“BLVD” or the “Company”) (TSXV:CXV), today announced an operational update as it further organizes for the next period of growth. As was previously announced on May 7, 2018, the Company is looking at opportunities to potentially enter the marijuana industry. It is reviewing several options, from acquiring assets to being acquired. Of course, if there is a bid to acquire BLVD, the acquisiti...

A director bought 1,152,000 shares at 0.145CAD and

A director at Convalo Health International Corp bought 1,152,000 shares at 0.145CAD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch